Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bronchiolitis in children

H B Panitch1, C W Callahan, D V Schidlow

  • 1Department of Pediatrics, St. Christopher's Hospital for Children, Philadelphia, Pennsylvania.

Clinics in Chest Medicine
|December 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Newer therapies for cystic fibrosis.

Paediatric respiratory reviews·2003
Same author

Lung function testing: chronic lung disease of infancy.

Pediatric pulmonology·2002
Same author

Uniformed pediatricians and humanitarian assistance.

Military medicine·2002
Same author

Reversal of bronchiectasis caused by chronic aspiration in cri du chat syndrome.

Archives of disease in childhood·2001
Same author

Pediatric Perspectives: Observations of an Older Pediatrician: Supplementing Evidence-based Medicine.

Pediatrics in review·2001
Same author

Multidisciplinary education and management program for children with asthma.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2001
Same journal

Pneumonia Reimagined: Host, Microbe, and the Shifting Landscape of Disease.

Clinics in chest medicine·2026
Same journal

Advocacy in Pneumonia.

Clinics in chest medicine·2026
Same journal

Vaccines Against Pneumonia: Current Updates.

Clinics in chest medicine·2026
Same journal

Non-antibiotic Treatments for Pneumonia: Host-Directed Therapies, Next-Steps and Future Directions.

Clinics in chest medicine·2026
Same journal

Customizing Antibiotic Treatment for Pneumonia: Can We Have a Single Unified Algorithm for All Types of Pneumonia?

Clinics in chest medicine·2026
Same journal

The Role of Complex Digital Interventions to Improve Pneumonia Care.

Clinics in chest medicine·2026
See all related articles

Bronchiolitis, a common infant respiratory infection caused by RSV, can lead to long-term issues. Ribavirin shows promise in treating RSV bronchiolitis and preventing lasting airway problems.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Pulmonology

Background:

  • Bronchiolitis is an acute airway inflammation in infants, commonly caused by Respiratory Syncytial Virus (RSV).
  • It presents as a lower respiratory tract infection with airway obstruction, typically lasting one week.
  • Severe cases or those with underlying conditions can result in significant morbidity and long-term sequelae like Persistent Bronchial Hyperresponsiveness (PBAR) and Obstructive Bronchitis (OB).

Purpose of the Study:

  • To review the pathogenesis of bronchiolitis, focusing on the role of RSV and host immune response.
  • To evaluate current and potential therapeutic strategies for managing bronchiolitis.
  • To explore the efficacy of antiviral agents, specifically ribavirin, in treating RSV-induced bronchiolitis and preventing long-term complications.

Related Experiment Videos

Main Methods:

  • Literature review of studies on bronchiolitis pathogenesis and treatment.
  • Analysis of clinical data regarding the effectiveness of various therapeutic modalities.
  • Examination of research on the immunomodulatory effects of antiviral agents like ribavirin.

Main Results:

  • RSV infection directly damages airways, with an exaggerated immune response potentially contributing to obstruction.
  • Oxygen and fluid resuscitation are standard care; corticosteroids are not supported, while bronchodilators show benefit in some patients.
  • Ribavirin demonstrates potential as an antiviral therapy for bronchiolitis and may mitigate immune responses to prevent sequelae.

Conclusions:

  • Bronchiolitis management requires supportive care, with specific treatments like bronchodilators and ribavirin showing promise.
  • Understanding the interplay between viral damage and immune response is crucial for preventing long-term airway issues.
  • Ribavirin offers a potential therapeutic avenue for both acute RSV infection and the prevention of chronic sequelae in bronchiolitis.